Orange Book product · Brand (NDA)
LOSEASONIQUE
ETHINYL ESTRADIOL; LEVONORGESTREL
At a glance
Oct 24, 2008
Approved
Brand (NDA)
Application
AB
TE code
1
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 24, 2008
17 yr 11 mo ago
Today
Patent 7855190 expires
Listed method-of-use patent (U-1) expiration.
Dec 05, 2028
in 2 yr 6 mo
Pharmaceutical detail
Active ingredient
ETHINYL ESTRADIOL; LEVONORGESTREL
Strength
0.02MG,0.1MG;0.01MG,N/A
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
NDA 022262
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a brand (NDA) product. Other products sharing this active ingredient are listed below.
- 2020TYBLUMEBrand (NDA)
NDA 209405 · EXELTIS USA INC
- 2020TWIRLABrand (NDA)
NDA 204017 · AGILE
- 2018BALCOLTRABrand (NDA)
NDA 208612 · AVION PHARMS
- 2013QUARTETTEBrand (NDA)
NDA 204061 · TEVA BRANDED PHARM
- 2007LYBRELBrand (NDA)
NDA 021864 · WYETH PHARMS INC
- 2006SEASONIQUEBrand (NDA)
NDA 021840 · TEVA BRANDED PHARM
- 2003SEASONALEBrand (NDA)
NDA 021544 · TEVA BRANDED PHARM
- 1998PREVEN EMERGENCY CONTRACEPTIVE KITBrand (NDA)
NDA 020946 · TEVA BRANDED PHARM
- 1998LEVLITEBrand (NDA)
NDA 020860 · BAYER HLTHCARE
- 1997ALESSEBrand (NDA)
NDA 020683 · CADENCE HEALTH
- 1984TRIPHASIL-21Brand (NDA)
NDA 019192 · WYETH PHARMS
- 1982NORDETTE-21Brand (NDA)
NDA 018668 · TEVA BRANDED PHARM
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 7855190 | Dec 05, 2028 | in 2 yr 6 mo | U-1 |
